Expression of the DCC gene in human hematological malignancies.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Leukemia and Lymphoma

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10428199409114135PMID 7696919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.

  1994cited by this paper
• Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.

  1993cited by this paper
• Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

  1993cited by this paper
• Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.

  1993cited by this paper
• DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18.

  1993cited by this paper
• Alterations in the deleted in colorectal carcinoma gene in human primary leukemia.

  1993cited by this paper
• Decreased expression of DCC mRNA in human colorectal cancers

  1993cited by this paper
• Expression of the DCC gene in myelodysplastic syndromes and overt leukemia.

  1993cited by this paper
• DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18

  1993cited by this paper
• Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma

  1993cited by this paper
• Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.

  1993cited by this paper
• Expression of the tumor suppressor gene DCC in human gliomas.

  1993cited by this paper
• p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia.

  1993cited by this paper
• Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome

  1993cited by this paper
• Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer

  1992cited by this paper
• Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

  1992cited by this paper
• Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.

  1992cited by this paper
• Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.

  1992cited by this paper
• Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

  1992cited by this paper
• Mutations of the p53 gene in adult T-cell leukemia.

  1992cited by this paper
• Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts.

  1992cited by this paper
• Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.

  1992cited by this paper
• DCC: a tumor suppressor gene expressed on the cell surface.

  1992cited by this paper
• SAM 1.1 and JOSH 4.4: two RFLPs within the human DCC gene.

  1992cited by this paper
• Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.

  1992cited by this paper
• Frequent loss of heterozygosity at the DCC locus in gastric cancer.

  1992cited by this paper
• P53 gene mutations in acute myeloid leukemia with 17p monosomy.

  1991cited by this paper
• The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.

  1991cited by this paper
• Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved?

  1991cited by this paper
• Inactivation of the retinoblastoma gene in human lymphoid neoplasms.

  1991cited by this paper
• p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

  1991cited by this paper
• Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18

  1991cited by this paper
• Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia.

  1991cited by this paper
• Scrambled exons.

  1991cited by this paper
• Mutations in the p53 gene in myelodysplastic syndromes.

  1991cited by this paper
• Mutations of the p53 gene in lymphoid leukemia.

  1991cited by this paper
• Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia.

  1991cited by this paper
• Mutation of the p53 gene in human acute myelogenous leukemia.

  1991cited by this paper
• Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia

  1991cited by this paper
• FMS mutations in myelodysplastic, leukemic, and normal subjects.

  1990cited by this paper
• Inherited and acquired genetic alterations in human colorectal cancer

  1990cited by this paper
• Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.

  1990cited by this paper
• Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line.

  1990cited by this paper
• Identification of a chromosome 18q gene that is altered in colorectal cancers.

  1990cited by this paper
• Identifying tumor suppressor genes in human colorectal cancer.

  1990cited by this paper
• Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Deletion of the human retinoblastoma gene in primary leukemias.

  1990cited by this paper
• Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

  1989cited by this paper
• Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia.

  1989cited by this paper
• Mechanisms of ras mutation in myelodysplastic syndrome.

  1989cited by this paper
• Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

  1989cited by this paper
• Mechanisms of ras mutation in myelodysplastic syndrome.

  1989cited by this paper
• Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.

  1988cited by this paper
• RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.

  1988cited by this paper
• RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.

  1987cited by this paper
• A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome

  1987cited by this paper
• Mutations of the Kirsten-ras proto-oncogene in human preleukaemia

  1987cited by this paper
• Myelodysplastic syndromes (preleukemia).

  1986cited by this paper
• Myelodysplastic syndromes (preleukemia).

  1986cited by this paper

• Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology

  2022cites this paper
• Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance

  2015cites this paper
• Netrin-1 and its receptors in tumour growth promotion.

  2008cites this paper
• Netrin-1 and its receptors in tumour growth promotion

  2008cites this paper
• Netrin-1: when a neuronal guidance cue turns out to be a regulator of tumorigenesis

  2005cites this paper
• Role of the dependence receptor DCC in colorectal cancer pathogenesis.

  2004cites this paper
• The dependence receptors DCC and UNC5H as a link between neuronal guidance and survival

  2003cites this paper
• [Abnormalities of the p53, N-ras, DCC and FLT-3 genes in myelodysplastic syndromes].

  2001cites this paper
• The myelodysplastic syndromes: towards a functional classification.

  1998cites this paper
• Myelodysplastic syndromes.

  1997cites this paper
• Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes.

  1997cites this paper
• DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis.

  1996cites this paper
• The DCC protein and prognosis in colorectal cancer.

  1996cites this paper